发明名称 8-AZAPROSTAGLANDIN DERIVATIVE COMPOUND OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF
摘要 <P>PROBLEM TO BE SOLVED: To provide compounds which strongly binds to the EP<SB>2</SB>subtype among PGE receptors, and are useful for preventive and/or treatment for immune diseases, allergic diseases, neuronal cell death, dysmenorrhea, premature birth, miscarriage, baldness, retinal neuropathy such as glaucoma, erectile dysfunction, arthritis, pulmonary injury, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, hepatic injury, acute hepatitis, liver cirrhosis, shock, nephritis, renal failure, circulatory diseases, systemic inflammatory response syndrome, sepsis, hemophagocytosis syndrome, macrophage activation syndrome, Still disease, Kawasaki Disease, burn, systemic granuloma, ulcerative colitis, Crohn disease, hypercytokinemia during dialysis, multiple organ failure, or bone diseases, etc. Ž<P>SOLUTION: The compounds are the 8-azaprostaglandin derivative compounds represented by formula (I-G), or pharmacologically acceptable salts thereof. Ž<P>COPYRIGHT: (C)2010,JPO&INPIT Ž
申请公布号 JP2010077142(A) 申请公布日期 2010.04.08
申请号 JP20090262122 申请日期 2009.11.17
申请人 ONO PHARMACEUT CO LTD 发明人 TANI KOSUKE;KOBAYASHI KAORU;MARUYAMA TORU;KANBE TORU;OGAWA MIKIO;SHIROYA TSUTOMU
分类号 C07D207/27;A61K31/4015;A61K31/4025;A61K31/403;A61K31/422;A61K31/423;A61K31/427;A61K31/4439;A61P1/00;A61P1/02;A61P1/04;A61P1/16;A61P5/14;A61P7/00;A61P7/06;A61P9/00;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P11/08;A61P13/12;A61P15/06;A61P15/08;A61P15/10;A61P17/02;A61P17/14;A61P19/00;A61P19/02;A61P19/08;A61P19/10;A61P21/04;A61P25/00;A61P27/02;A61P27/06;A61P27/16;A61P29/00;A61P31/04;A61P35/00;A61P35/04;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D207/26;C07D207/28;C07D263/24;C07D401/12;C07D403/06;C07D405/06;C07D405/12;C07D405/14;C07D409/06;C07D409/12;C07D409/14;C07D413/06;C07D413/12;C07D413/14;C07D417/06;C07D417/12;C07D417/14 主分类号 C07D207/27
代理机构 代理人
主权项
地址